← Back to Calendar
Live Company Data
NMS
Updated
3m ago
· Data: FMP
Current Price
$36.37
+804.73%
+$32.35 today
Day: $35.82 – $37.58
Market Cap
N/A
Shares out: 162.31M
Float: 150.97M
52-Week Range
Current price is at 81% of 52-week range
Sector
Healthcare
Biotechnology
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Advanced systemic mastocytosis (AdvSM)
Key Notes
APEX trial Phase 2 data. Bezuclastinib is a highly selective KIT D816V inhibitor for systemic mastocytosis. Expected presentation at a major oncology conference mid-2026. NDA filing planned following data.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.